Cargando…
A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5
Multiple myeloma (MM) is a disease of copy number variants (CNVs), chromosomal translocations, and single-nucleotide variants (SNVs). To enable integrative studies across these diverse mutation types, we developed a capture-based sequencing platform to detect their occurrence in 465 genes altered in...
Autores principales: | White, Brian S., Lanc, Irena, O’Neal, Julie, Gupta, Harshath, Fulton, Robert S., Schmidt, Heather, Fronick, Catrina, Belter, Edward A., Fiala, Mark, King, Justin, Ahmann, Greg J., DeRome, Mary, Mardis, Elaine R., Vij, Ravi, DiPersio, John F., Levy, Joan, Auclair, Daniel, Tomasson, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862875/ https://www.ncbi.nlm.nih.gov/pubmed/29563506 http://dx.doi.org/10.1038/s41408-018-0062-y |
Ejemplares similares
-
IGLL5 is correlated with tumor‐infiltrating immune cells in clear cell renal cell carcinoma
por: Xia, Zhi‐Nan, et al.
Publicado: (2021) -
Super Enhancer Regulatory Gene FYB1 Promotes the Progression of T Cell Acute Lymphoblastic Leukemia by Activating IGLL1
por: Zhang, Kunlong, et al.
Publicado: (2023) -
Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
por: Hathi, Deep, et al.
Publicado: (2022) -
Co-evolution of tumor and immune cells during progression of multiple myeloma
por: Liu, Ruiyang, et al.
Publicado: (2021) -
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
por: Alhallak, Kinan, et al.
Publicado: (2021)